Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas
Launched by ONIRIS · Aug 24, 2016
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients \> 18 years treated with Mandibular Advancement Device Tali® from at least 2 years and at the latest 5 years.
- • Patients who agree to participate to the study.
About Oniris
Oniris is a pioneering clinical trial sponsor dedicated to advancing medical research through innovative solutions and robust study designs. With a focus on improving patient outcomes, Oniris specializes in the development and management of clinical trials across various therapeutic areas. The organization is committed to maintaining the highest standards of ethics and compliance while fostering collaboration among stakeholders. By leveraging cutting-edge technology and a team of experienced professionals, Oniris aims to accelerate the delivery of new therapies and enhance the overall efficiency of the clinical research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials